Jefferies Financial Group Inc. Has $27.98 Million Holdings in Embecta Corp. $EMBC

Jefferies Financial Group Inc. lifted its position in shares of Embecta Corp. (NASDAQ:EMBC) by 24.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,354,971 shares of the company’s stock after purchasing an additional 470,096 shares during the quarter. Jefferies Financial Group Inc. owned approximately 3.98% of Embecta worth $27,977,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. LSV Asset Management grew its holdings in shares of Embecta by 92.5% during the 4th quarter. LSV Asset Management now owns 552,582 shares of the company’s stock worth $6,565,000 after purchasing an additional 265,482 shares in the last quarter. Isthmus Partners LLC grew its holdings in shares of Embecta by 4.8% during the 4th quarter. Isthmus Partners LLC now owns 138,729 shares of the company’s stock worth $1,648,000 after purchasing an additional 6,323 shares in the last quarter. Swiss Life Asset Management Ltd acquired a new stake in shares of Embecta during the 4th quarter worth approximately $145,000. Yacktman Asset Management LP grew its holdings in shares of Embecta by 3.2% during the 4th quarter. Yacktman Asset Management LP now owns 2,262,915 shares of the company’s stock worth $26,883,000 after purchasing an additional 71,209 shares in the last quarter. Finally, Tweedy Browne Co LLC grew its holdings in shares of Embecta by 16.7% during the 4th quarter. Tweedy Browne Co LLC now owns 48,191 shares of the company’s stock worth $573,000 after purchasing an additional 6,912 shares in the last quarter. Institutional investors and hedge funds own 93.83% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on EMBC. Wall Street Zen lowered Embecta from a “strong-buy” rating to a “hold” rating in a report on Saturday, May 9th. Zacks Research lowered Embecta from a “hold” rating to a “strong sell” rating in a report on Friday, May 8th. Weiss Ratings lowered Embecta from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, May 6th. BTIG Research lowered Embecta from a “buy” rating to a “neutral” rating in a research note on Tuesday, May 5th. Finally, Mizuho decreased their price target on Embecta from $12.00 to $5.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Two research analysts have rated the stock with a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Strong Sell” and an average target price of $11.00.

Embecta Stock Performance

Shares of EMBC opened at $3.32 on Friday. The stock has a fifty day moving average price of $7.44 and a two-hundred day moving average price of $10.26. Embecta Corp. has a 52-week low of $2.77 and a 52-week high of $15.55. The company has a market cap of $196.98 million, a price-to-earnings ratio of 1.75 and a beta of 1.09.

Embecta (NASDAQ:EMBC) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.42 by ($0.15). Embecta had a net margin of 10.73% and a negative return on equity of 23.96%. The business had revenue of $221.80 million during the quarter, compared to the consensus estimate of $235.67 million. During the same quarter in the previous year, the firm posted $0.70 EPS. The company’s revenue for the quarter was down 14.4% compared to the same quarter last year. Embecta has set its FY 2026 guidance at 1.550-1.75 EPS. As a group, research analysts predict that Embecta Corp. will post 1.62 EPS for the current fiscal year.

Embecta Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Thursday, May 28th will be given a $0.01 dividend. The ex-dividend date is Thursday, May 28th. This represents a $0.04 annualized dividend and a yield of 1.2%. Embecta’s payout ratio is presently 31.58%.

About Embecta

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.

The company’s product portfolio includes insulin infusion sets, durable and patch pumps, pen needles, infusion tubing, blood glucose test strips, lancets and lancing devices.